Suming Pan

机构：Shantou University, Yue Bei People's Hospital · ORCID：0000-0003-0005-5602

发表论文 14 篇 · 总被引 474 次 · h-index 8

代表论文

• CD36 inhibits β-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis (2019 · Nature Communications · 被引 253)
• Cancer stem-like cell: a novel target for nasopharyngeal carcinoma therapy (2014 · Stem Cell Research & Therapy · 被引 40)
• Upfront Cranial Radiotherapy vs. EGFR Tyrosine Kinase Inhibitors Alone for the Treatment of Brain Metastases From Non-small-cell Lung Cancer: A Meta-Analysis of 1465 Patients (2018 · Frontiers in Oncology · 被引 35)
• MiR-29c regulates the expression of miR-34c and miR-449a by targeting DNA methyltransferase 3a and 3b in nasopharyngeal carcinoma (2016 · BMC Cancer · 被引 32)
• Research status and prospects of biomarkers for nasopharyngeal carcinoma in the era of high‑throughput omics (Review) (2021 · International Journal of Oncology · 被引 27)
• Expression profile and bioinformatics analysis of COMMD10 in BALB/C mice and human (2019 · Cancer Gene Therapy · 被引 24)